Antara Senior Care receives occupancy certificate for Noida community

1 min read     Updated on 28 May 2026, 09:50 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Antara Senior Care, a subsidiary of Max India, received a partial occupancy certificate for its Noida Sector 150 project, covering 3 towers and 340 units in Phase I. This unlocks ₹150 crore in receivables and allows 340 families to take possession, with Phase I revenue at ₹550 crore and Phase II estimated at ₹800 crore.

powered bylight_fuzz_icon
41405272

*this image is generated using AI for illustrative purposes only.

Max India 's senior living arm, Antara Senior Care, has received a partial occupancy certificate for its residential community in Noida Sector 150. This regulatory clearance covers 3 towers and 340 units in Phase I, enabling 340 senior families to take possession of their homes. The development is expected to unlock approximately ₹150 crore in receivables that were contingent on possession, marking a significant financial milestone for the company.

Project and Financial Details

The receipt of the occupancy certificate follows the company's fulfillment of all payment obligations related to shared sports facilities in the sector. To expedite possession, the company approached the Noida Authority and the courts, including the Supreme Court of India, to establish its compliance. The total development spans approximately 12 lakh sq. ft., with Phase I accounting for approximately 7.45 lakh sq. ft. and Phase II covering the remaining 4.55 lakh sq. ft.

The following table outlines the revenue performance and estimates associated with the Noida Sector 150 project:

Parameter Details
Occupancy Certificate Received for Phase I (3 towers, 340 units)
Receivables Unlocked Approximately ₹150 crore
Phase I Revenue Approximately ₹550 crore
Phase II Estimated Revenue Approximately ₹800 crore

Operational Significance

Mr Rajit Mehta, MD & CEO, Antara Senior Care, stated that the team is actively reviewing the conditions laid down in the certificate and expects to start the grant of possession soon. With Phase I on the path to possession, the company will actively pursue the revalidation of approvals for Phase II. The community is designed for seniors seeking an independent lifestyle, offering residences integrated with wellness and medical services.

Historical Stock Returns for Max India

1 Day5 Days1 Month6 Months1 Year5 Years
-0.83%-8.42%+1.82%-18.50%-12.85%+139.53%

What is the expected timeline for securing the occupancy certificate for Phase II and unlocking the remaining ₹800 crore in estimated revenue?

How will the immediate inflow of ₹150 crore in receivables impact Max India’s capital allocation strategy and debt reduction plans?

What specific legal or regulatory hurdles does Antara anticipate during the revalidation of approvals for Phase II?

Max India Limited Appoints Former McKinsey Senior Partner Mrinalini Mirchandani as Independent Director

1 min read     Updated on 10 Apr 2026, 03:07 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Max India Limited's Board of Directors approved the appointment of Ms. Mrinalini Mirchandani as Additional Independent Director for a five-year term from April 15, 2026 to April 14, 2031. Ms. Mirchandani, a former Senior Partner at McKinsey & Company and the first woman to hold this position in the firm's 34-year India history, brings extensive experience in private equity, healthcare, and strategic consulting. The appointment, subject to shareholder approval, complies with SEBI listing regulations.

powered bylight_fuzz_icon
37316230

*this image is generated using AI for illustrative purposes only.

Max India Limited has announced the appointment of Ms. Mrinalini Mirchandani as Additional Director in the capacity of Independent Director. The Board of Directors approved this appointment on April 9, 2026 via circular resolution, following the recommendation of the Nomination and Remuneration Committee.

Appointment Details

The appointment encompasses a five-year term commencing on April 15, 2026 and concluding on April 14, 2031. The decision is subject to approval from shareholders and has been disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter: Details
Director Name: Ms. Mrinalini Mirchandani
DIN: 11619010
Position: Additional Director (Independent Director)
Term Duration: 5 years
Commencement Date: April 15, 2026
End Date: April 14, 2031
Approval Status: Subject to shareholder approval

Professional Background

Ms. Mirchandani brings distinguished experience from her tenure at McKinsey & Company, where she served as Senior Partner. She holds the distinction of being the first and only woman elected to the Senior Partner position in McKinsey's 34-year history in India.

At McKinsey, she led the Private Equity Practice in India and served as a member of the global healthcare leadership team. Her responsibilities also included overseeing the Organization & Talent practice in India. Prior to McKinsey, she worked at Merrill Lynch, leading their Healthcare & Consumer Investment Banking Team in India, and headed the Healthcare recruiting practice for Egon Zehnder in India.

Educational Qualifications and Recognition

Ms. Mirchandani holds an MBA from IIM Calcutta and a B.Com from Mumbai University. Her professional achievements were recognized in 2018 when she was featured in the Economic Times list of India's 40 under Forty Young Business Leaders.

Regulatory Compliance

The company has confirmed that Ms. Mirchandani is not related to any other Director of the Company and is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other authority. The appointment disclosure complies with all requirements under SEBI listing regulations and relevant circulars.

Over the past two decades, Ms. Mirchandani has collaborated with leading Indian and global institutions on various strategic initiatives including growth strategy, mergers and acquisitions, capital raising, talent management, and delivering transformational change at scale.

Historical Stock Returns for Max India

1 Day5 Days1 Month6 Months1 Year5 Years
-0.83%-8.42%+1.82%-18.50%-12.85%+139.53%

What strategic initiatives or transformation plans might Max India be considering that would benefit from Ms. Mirchandani's private equity and healthcare expertise?

How could Ms. Mirchandani's M&A experience at McKinsey influence Max India's potential acquisition or divestiture strategies in the coming years?

Will Max India's board composition changes signal a shift toward more healthcare-focused investments or operational improvements?

More News on Max India

1 Year Returns:-12.85%